UCLA Campus    |   UCLA Health    |   School of Medicine Translate:
UCLA Health It Begins With U

UCLA Transplantation Services

Print
Email
Share

Cardiomyopathy

Ahmanson-UCLA Cardiomyopathy Center

Ahmanson-UCLA Cardiomyopathy The multidisciplinary Ahmanson-UCLA Cardiomyopathy Center provides comprehensive diagnostic and therapeutic services to patients with heart failure and/or cardiomyopathy (diseases of the heart muscle). Patients range from those with risk factors for heart failure or silent ventricular enlargement or dysfunction to those with advanced heart failure requiring evaluation for heart transplanation.

Since the Ahmanson-UCLA Cardiomyopathy Center opened in 1984 along with the UCLA Cardiac Transplant Program, the Center's physicians have developed new principles for the design of medical therapy for heart failure patients based on the recognition that heart failure is not one disease but a unique combination of disorders in each patient. Through this work, the staff of the Center have become internationally recognized for their contribution to the understanding of heart failure and the advancement of therapy to improve function and prolong life for patients with these problems.

For patients with major symptoms of heart failure, a special program of comprehensive heart failure disease management is designed to optimize heart function for each individual based on response to different medications. Many of the most severely ill patients treated at the Center, those who have previously failed all attempts at therapy and been unable to be discharged from the hospital, have been able to go home and begin a regular exercise program after undergoing therapy at UCLA. Among patients with heart failure symptoms at the time of referral, almost all report better quality of life after receiving new therapy and education about how to participate actively in their own care.

From our extensive experience, we have learned the value of instituting optimal therapy with systematic non-invasive re-evaluation not only for advanced disease, but also for the patients with early cardiomyopathy or risk factors for heart failure. With a coordinated program of specialized attention, many of those patients can avoid the progression to heart failure and thus not require transplantation.

The Ahmanson-UCLA Cardiomyopathy Center offers a full range of treatment alternatives, including cardiac transplantation, bridging mechanical assist devices, and cardiac resynchronization therapy in addition to comprehensive heart failure disease management and risk assessment. The Center includes the outpatient Heart Failure Clinic, the inpatient Advanced Cardiac Evaluation (ACE) Unit, the Exercise Laboratory, the UCLA Cardiac Arrhythmia Center, and the Cardiac Transplantation Clinic. The Center also is closely affiliated with the UCLA Cardiothoracic Surgery Service.

Heart Failure

Heart failure affects nearly 6 million Americans and as more patients are surviving myocardial infarction but being left with reduced ventricular function, heart failure is the only major cardiovascular disease still increasing in incidence. An estimated 400,000 to 700,000 new cases of heart failure are diagnosed each year and the number of deaths in the US from this condition has more than doubled since 1979, averaging 250,000 annually. In comparison, the death rate from coronary heart disease has dropped by 49% over a similar time period. An estimated 8-15 billion dollars is spent each year on the costs of hospitalization, which is twice the amount spent on all forms of cancer combined.

The Ahmanson-UCLA Cardiomyopathy Center has lead efforts in identifying new therapies and approaches to manage heart failure over the last 2 decades. Recent scientific research and clinical trials have identified medical therapies, devices, and disease management strategies that can offer patients markedly improved quality of life, reduced risk of hospitalization, and improve survival.

Meet our Team

Gregg C. Fonarow, M.D. Gregg C. Fonarow, M.D. 

Mario Deng, M.D. Mario Deng, M.D.

Daniel Cruz, M.D. Daniel Cruz, M.D.  

Tamara Horwich, M.D. Tamara Horwich, M.D.  

Ali Nsair, M.D. Ali Nsair, M.D.

Allison Kean, M.D. Allison Kean, M.D.  

Reza Ardehali, M.D., Ph.D. Reza Ardehali, M.D., Ph.D. 

Martin Cadeiras, M.D. Martin Cadeiras, M.D. 

Eugene DePasquale, M.D. Eugene DePasquale, M.D. 

Arnold Baas, M.D.

Jessica Wang, M.D.
 

Julie W. Creaser, RN, MN, CHFN Julie W. Creaser RN, MN, CHFN

Beth Vandenbogaart, RN, MSN, ACNP-BC Beth Vandenbogaart RN, MSN, ACNP-BC

Tamara Chaker, RN, MSN, ACNP-BC Tamara Chaker RN, MSN, ACNP-BC

Darlene Rourke RN, MSN, CHFN

Nancy Livingston RN, MN, FNP-BC

Contact Us

UCLA Cardiovascular Center
100 UCLA Medical Plaza, Suite 630 - East
Los Angeles, CA 90095
Phone: (310) 825-8816
Fax: (310) 825-9013
chf@mednet.ucla.edu

UCLA Rated One of the Top Hospitals in the Nation